The third Catalyst Centre tenant revealed

Following a competitive process which involved pitching to our seasoned panel of judges, we are excited to reveal the next business that will be joining EasyVideo and Carena Healthcare in the Catalyst Centre this autumn.

Renovos is a new company based in Southampton, capitalising on decades of multidisciplinary orthopaedic research. Its co-founders, Professor Richard Oreffo and Dr Jonathan Dawson, stem from a pioneering skeletal regenerative medicine group at University of Southampton. The company aims to be a leader in bone repair technologies, providing cross-functional orthopaedic services and solutions, and will initially offer research-grade high-quality bone marrow stem cell populations, a rapid and low-cost screening tool for researching into novel biomaterials and a nanoclay-gel biomaterial for more effective localised delivery of bone healing agents and tissue repair.

The ingenious nanoclay-gel has the potential to revolutionise bone repairs in both humans and animals, and is of particular benefit to the millions of people who suffer osteoporosis (weak bones). The UK’s ageing population is well documented but the impact of osteoporosis less so. Worldwide there are over 9 million fractures annually, resulting in an osteoporotic fracture every 3 seconds! In the UK one in two women and one in five men over 50 will experience an osteoporotic fracture. All bone fractures cost the NHS over £2bn each year and yet, unfortunately, many such fractures do not heal effectively with up to 10% of fractured bones failing to realign properly. Renovos’s innovative approach aims to help clinicians heal bone fractures in a more cost-effective and easy-to-use way.

The nanoclay-gel solution encapsulates biological agents in a one-step procedure without the need for complex chemical or physical methods. An injectable and sprayable slow-release formula, it works in a localised manner with anticipated improved patient safety compared to alternatives on the market. Product testing is underway and there’s significant interest building across several market applications.


Catalyst judges all agreed on the huge market potential for this groundbreaking product and were delighted to offer Renovos a place in the Catalyst Centre. Business Development Manager and Scientist, Dr Agnieszka Janeczek said, “We’re very excited about being enrolled into the Catalyst Programme and we hope that with the support and mentoring provided we’ll be able to create a viable business within the orthopaedic regenerative medicine field.”

In the weeks to come, we will be interviewing more of the Renovos team to find out what they want to achieve from their Catalyst experience, but in the meantime, we congratulate them on their successful pitch and look forward to welcoming them to the University of Southampton Science Park.